TY - JOUR
T1 - Cutting edge
T2 - Constitutive B cell receptor signaling is critical for basal growth of B lymphoma
AU - Gururajan, Murali
AU - Jennings, C. Darrell
AU - Bondada, Subbarao
PY - 2006/5/15
Y1 - 2006/5/15
N2 - B lymphomas account for the majority of the lymphoma cases. BCR expression appears to be important for B lymphoma because most oncogenes are translocated to nonrearranged Ig loci and because all of the variants that arise in anti-idiotypic Ab-treated lymphoma patients remain BCR positive. Based on this and the fact that BCR is required for mature B cell survival, we tested the requirement for continued expression of BCR for the growth and survival of B lymphoma cells. Using Igα or Igβ-specific small interfering RNA (siRNA) to inhibit BCR expression, we demonstrate for the first time that constitutive signaling by BCR is critical for survival and proliferation of both murine and human B lymphoma cells. The BCR signals in lymphoma appear to be mediated by Syk, as it is constitutively active in a variety of B lymphoma cells. Blocking Syk activity by selective inhibitors suppresses growth of several murine and human B lymphomas.
AB - B lymphomas account for the majority of the lymphoma cases. BCR expression appears to be important for B lymphoma because most oncogenes are translocated to nonrearranged Ig loci and because all of the variants that arise in anti-idiotypic Ab-treated lymphoma patients remain BCR positive. Based on this and the fact that BCR is required for mature B cell survival, we tested the requirement for continued expression of BCR for the growth and survival of B lymphoma cells. Using Igα or Igβ-specific small interfering RNA (siRNA) to inhibit BCR expression, we demonstrate for the first time that constitutive signaling by BCR is critical for survival and proliferation of both murine and human B lymphoma cells. The BCR signals in lymphoma appear to be mediated by Syk, as it is constitutively active in a variety of B lymphoma cells. Blocking Syk activity by selective inhibitors suppresses growth of several murine and human B lymphomas.
UR - http://www.scopus.com/inward/record.url?scp=33646492861&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646492861&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.176.10.5715
DO - 10.4049/jimmunol.176.10.5715
M3 - Article
C2 - 16670274
AN - SCOPUS:33646492861
SN - 0022-1767
VL - 176
SP - 5715
EP - 5719
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -